Literature DB >> 9088034

Low-grade myxofibrosarcoma: progression in recurrence.

M Fukunaga1, N Fukunaga.   

Abstract

A case of low-grade myxofibrosarcoma with histologic progression in recurrence occurring in a 51-year-old male is described. The patient had a well-circumscribed encapsulated myxoid mass, which measured 2.5 cm at its greatest diameter, in the subcutis of the left forearm. Microscopically, the tumor was characterized by a proliferation of sparsely distributed spindle or stellate cells, curvilinear small vessels and myxoid stroma. It demonstrated mild pleomorphism without mitotic figures. The patient had the first recurrence at 3 years, which was histologically identical to the primary tumor. The patient had a second recurrence at 11 years, which was predominantly composed of sheets of anaplastic, rounded or oval cells with focal osteoid formation. Immunohistochemically, the tumor cells in the primary and the first recurrent lesions were focally positive for vimentin. In the second recurrence, the tumor cells contained vimentin, alpha-smooth muscle actin and muscle specific actin (HHF35). The primary lesion had a diploid DNA content with low S-phase fractions. The second recurrence showed a polyploidy. The patient was well with no evidence of disease 18 months after the second recurrence. These findings suggest that this neoplasm showed histological progression with an increasing risk of metastasis. Low-grade myxofibrosarcoma, which commonly is misinterpreted as benign, has a tendency for histological and biological progression in local recurrences, underlining the importance of accurate diagnosis and wide surgical excision of the primary lesion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088034     DOI: 10.1111/j.1440-1827.1997.tb03734.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Prognostic factors and outcomes of patients with myxofibrosarcoma.

Authors:  G Petur Nielsen; John T Mullen; Nicole J Look Hong; Francis J Hornicek; Kevin A Raskin; Sam S Yoon; Jackie Szymonifka; Beow Yeap; Yen-Lin Chen; Thomas F DeLaney
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

2.  Oncological Outcomes in Patients with Appendicular Myxofibrosarcomas: A Retrospective Study.

Authors:  Yonghoon Lee; Michael P Guertin; Spencer Summers; Sheila A Conway; Mothasem Al Maaieh; Raphael Yechieli; Jonathan Trent; Andrew E Rosenberg; Juan Pretell-Mazzini
Journal:  J Oncol       Date:  2021-11-28       Impact factor: 4.375

3.  Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.

Authors:  Vittoria Colia; Marco Fiore; Salvatore Provenzano; Elena Fumagalli; Rossella Bertulli; Carlo Morosi; Angelo P Dei Tos; Marta Barisella; Alessandro Gronchi; Paolo G Casali; Roberta Sanfilippo
Journal:  Clin Sarcoma Res       Date:  2017-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.